Early hydroxychloroquine macular toxicity.
This report describes the case of an appropriately dosed patient who developed maculopathy <8 years after starting hydroxychloroquine (HCQ) therapy for systemic lupus erythematosus. Risk factors and screening for HCQ-associated maculopathy are discussed.
Warner
A E
AE
D000328:Adult; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects* / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008268:Macular Degeneration / Q000139:chemically induced*
D006886:Hydroxychloroquine